Related Experiment Video
Updated: Nov 5, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies
Xingjin Yang1, Dongdong Zhang2, Yang Zhao1
1Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
Insights
Higher C-reactive protein (CRP) levels significantly increase the risk of cardiovascular events (CVEs), including cardiovascular disease, stroke, and coronary heart disease. This quantitative analysis confirms a dose-response relationship between CRP and CVE risk.
Area of Science:
- Cardiology
- Biomarkers
- Epidemiology
Background:
- Serum C-reactive protein (CRP) is a known inflammation marker.
- Previous studies suggest an association between CRP levels and cardiovascular events (CVEs).
- A comprehensive quantitative assessment of this association was lacking.
Purpose of the Study:
- To quantitatively evaluate the association between serum CRP levels and the risk of CVEs.
- To assess the dose-response relationship between CRP and cardiovascular disease (CVD), stroke, and coronary heart disease (CHD).
Main Methods:
- Meta-analysis of 36 articles (60 studies; 227,715 participants) from PubMed and Embase up to December 6, 2019.
- Generalized least-squares regression models and restricted cubic splines were used.
- Studies were treated independently to include diverse populations and CVE types.
Main Results:
- High versus low CRP levels showed pooled relative risks (RRs) of 1.64 for CVD, 1.46 for stroke, and 1.55 for CHD.
- A linear association was observed between CRP levels and CVEs.
- Each 1-mg/L increase in CRP was associated with RRs of 1.18 for CVD, 1.07 for stroke, and 1.12 for CHD.
Conclusions:
- Serum CRP level is a significant predictor of cardiovascular event risk.
- Increasing CRP levels correlate with a progressively higher risk of CVD, stroke, and CHD.
- This meta-analysis provides quantitative evidence supporting CRP as a risk factor for cardiovascular events.
Abstract:
Although the association between serum level of C-reactive protein (CRP) and risk of cardiovascular events (CVEs) has been reported, the comprehensive assessment of the quantitative association of CRP level with risk of CVEs has not been reported. Our meta-analysis aims to quantitatively evaluate the association of CRP level and risk of CVEs. We searched PubMed and Embase databases for articles published up to December 6, 2019. Studies with data on men and women, different types of CVEs and multiple cohorts within a study were treated as independent studies. Generalized least-squares regression models were used to assess the quantitative association between CRP level and risk of CVEs. Restricted cubic splines were used to model the possible linear association between CRP and CVEs. We included 36 articles (60 studies; 227,715 participants) in the analysis. The pooled relative risks (RRs) of high versus low CRP level for cardiovascular disease (CVD), stroke and coronary heart disease (CHD) were 1.64 (95% confidence interval [CI], 1.49-1.82), 1.46 (95% CI, 1.35-1.58), and 1.55 (95% CI, 1.47-1.63), respectively. A linear association was found between CRP level and CVD (P = 0.429), stroke (P = 0.940), and CHD (P = 0.931); with each 1-mg/L increase in CRP level, the pooled RRs for CVD, stroke, and CHD were 1.18 (95% CI, 1.12-1.24), 1.07 (95% CI, 1.04-1.09), and 1.12 (95% CI, 1.08-1.16), respectively. This meta-analysis suggests that risk of CVEs increases with increasing serum CRP level.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk